GNBT News and Press, Generex Biotechnology From 01/08/20

2020 Wall Street Conference & Retreat West Palm Beach, FL, February 19 – 20, 2020 MIRAMAR, Fla., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB:GNBT) is pleased to announce that the company has been selected as the featured organization to present ...

Awaiting completion of FINRA approval process New dates projected for shareholder stock dividends • New Pay Date: January 10, 2020 • New Ex-Date: January 13, 2020 • Record Date remains August 30, 2019 Dividends remain the same • Shareholders to receive 2 to 5 ...

MIRAMAR, Fla., Dec. 11, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) is proud to announce the appointment of Dr. Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology (NGIO) Board of Directors...

Generex will give a 2 to 5 stock dividend to shareholders paying 2 GNBT shares for every 5 shares held Shareholders to receive an additional 2 to 5 stock dividend of NuGenerex Immuno-Oncology shares New Dates Established for shareholder stock dividend New Pay Date: January 3, 2020 New...

MIRAMAR, Fla., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB: GNBT) today provided guidance on the postponed stock dividend. Tomorrow, Tuesday December 10, 2019 at 9:30 AM, Generex will announce the new pay date and ex-date for the dividend and will announce a n...

MIRAMAR, Fla., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB: GNBT) is pleased to announce that the company has finalized agreements to provide significant funding for ongoing operations, launching new businesses, and advancing the commercial development of new ...

MIRAMAR, Fla., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB: GNBT) today announced that due to the issues announced yesterday in a shareholder alert, and because of the resulting sharp decline of over 150% in our share price, the Company has decided to postpone...

MIRAMAR, Fla., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the following access information for its investor conference call, to be hosted by President & Chief Executi...

Closing Scheduled for December 2019 Patented AltuCaps®  for Microencapsulation of stem cells for autoimmune and inflammatory diseases: Partnering opportunities available Altsulin® implantable Sertoli Cells for Type I Diabetes New technology: Patented, next generation, ...

MIRAMAR, Fla., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) today announced that it will hold an investor conference call on Friday November 29, 2019 at 9:30 am. Joseph Moscato, Generex President & Chief Executive Officer stated...